Brief: Urogen Pharma Received A Paragraph IV Certification Notice Letter From Teva Pharmaceuticals, Inc

UroGen Pharma

01/03/2024 13:29

March 1 (Reuters) - Urogen Pharma Ltd  UR8.F :
    * UROGEN PHARMA LTD -  RECEIVED A PARAGRAPH IV CERTIFICATION
NOTICE LETTER FROM TEVA PHARMACEUTICALS, INC
    * UROGEN PHARMA-  NOTICE LETTER SAYS TEVA SUBMITTED ANDA TO
U.S.
FDA FOR APPROVAL TO MAKE GENERIC VERSION OF JELMYTO FOR
PYELOCALICEAL SOLUTION
    * UROGEN PHARMA LTD -  IN NOTICE LETTER, TEVA ALLEGES 2
PATENTS
FOR JELMYTO WILL NOT BE INFRINGED BY TEVA'S MANUFACTURE OF
GENERIC PRODUCT IN ANDA

Source text for Eikon:  ID:n0001193125-24-054393 
Further company coverage:  UR8.F 

 ((Reuters.Briefs@thomsonreuters.com;))